Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. (Q45928405)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 July 2009

Language	Label	Description	Also known as
English	Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.	scientific article published on 15 July 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

1 reference

based on heuristic

inferred from title

Hiroharu Yamashita

10

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

author name string

H Ishigami

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

J Kitayama

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

S Kaisaki

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

A Hidemura

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

M Kato

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

K Otani

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

T Kamei

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

D Soma

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

H Miyato

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

H Nagawa

11

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

language of work or name

1 reference

based on heuristic

inferred from title

publication date

15 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

21

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

67-70

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Disparities in gastric cancer chemotherapy between the East and West

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 960

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

A Phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Chemotherapy for metastatic disease: review from JCOG trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Prevention of peritoneal metastasis of human gastric cancer cells in nude mice by S-1, a novel oral derivative of 5-Fluorouracil

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Phase I and pharmacokinetic study of S-1 combined with weekly paclitaxel in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Japanese Classification of Gastric Carcinoma - 2nd English Edition -

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Paclitaxel-induced apoptosis in human gastric carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Identifiers

10.1093/ANNONC/MDP260

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45928405&oldid=1620018864"